MFDA Calls For Legal Amendment to Allow Import Of ADHD Medication
MFDA highlights challenges in importing ADHD medication | Photo: People’s Majlis
The Maldives Food and Drug Authority (MFDA) has highlighted major obstacles in importing medication for Attention Deficit Hyperactivity Disorder (ADHD), citing its classification under national law as an intoxicating substance.
The classification currently prevents the entry of the drug into the country, despite global scientific consensus recognising its effectiveness in treating ADHD.
advertisement
advertisement
advertisement
The Parliament’s Petitions Committee held discussions yesterday with officials from the Ministry of Health and the MFDA regarding a petition submitted by Mohamed Ibrahim, the Maldivian Democratic Party (MDP) MP for Galolhu North. The petition, endorsed by 47 parents, underscored the severe shortage of therapy services for children and individuals with disabilities, and the lack of access to essential medication and medical devices for those with conditions such as autism and ADHD.
Aishath Jaleela, Director of Pharmaceuticals at the MFDA, identified methylphenidate as the unavailable drug. She confirmed that the authority has received repeated complaints from both patients and medical professionals regarding its absence. While methylphenidate is recognised internationally as an effective treatment for ADHD and is listed under the Maldives’ Drugs Act as an essential medicine, its inclusion in Articles One and Two of the Narcotics Act as an abusive substance blocks its legal import.
To address this issue, the MFDA has requested a legal amendment to shift methylphenidate from Schedule I to Schedule II under the Narcotics Act. A formal appeal was sent to Parliament on 13 July 2025.
The petition also raised concerns about long waiting times for therapy services, high treatment costs, and limited government assistance. It further called for an investigation into the National Social Protection Agency (NSPA) over alleged failures to provide therapy and other crucial medical support for children and individuals with disabilities. Related requests for inquiries have been submitted to the Human Rights Commission of the Maldives, the Ministry of Family and Social Affairs, NSPA, and the Disability Commission.
